iQur is at the forefront of vaccine research and development, using tandem core technology to create novel vaccines, currently being developed for influenza, malaria, human cytomegalovirus, dengue fever and hepatitis C.
iQur is at the forefront of vaccine research and development, using tandem core technology to create novel vaccines, currently being developed for influenza, malaria, human cytomegalovirus, dengue fever and hepatitis C.